Parcells MS[au] - Search Results

Year	Number of Results
1994	2
1995	1
1997	1
1998	1
1999	2
2000	1
2001	2
2003	3
2004	3
2006	2
2009	4
2012	1
2013	1
2016	2
2018	4
2019	5
2020	3
2021	4
2022	1
2023	0

1

Retention of oncogenicity by a Marek's disease virus mutant lacking six unique short region genes.

Parcells MS, Anderson AS, Morgan TW. Parcells MS, et al. J Virol. 1995 Dec;69(12):7888-98. doi: 10.1128/JVI.69.12.7888-7898.1995. J Virol. 1995. PMID: 7494301 Free PMC article.

2

Establishment of a lymphoblastoid cell line using a mutant MDV containing a green fluorescent protein expression cassette.

Dienglewicz RL, Parcells MS. Dienglewicz RL, et al. Among authors: parcells ms. Acta Virol. 1999 Apr-Jun;43(2-3):106-12. Acta Virol. 1999. PMID: 10696429

3

Understanding animal viruses using the Gene Ontology.

McCarthy FM, Mahony TJ, Parcells MS, Burgess SC. McCarthy FM, et al. Among authors: parcells ms. Trends Microbiol. 2009 Jul;17(7):328-35. doi: 10.1016/j.tim.2009.04.006. Epub 2009 Jul 2. Trends Microbiol. 2009. PMID: 19577474 Review.

4

Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Parcells MS, Dienglewicz RL, Anderson AS, Morgan RW. Parcells MS, et al. J Virol. 1999 Feb;73(2):1362-73. doi: 10.1128/JVI.73.2.1362-1373.1999. J Virol. 1999. PMID: 9882341 Free PMC article.

5

An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.

Guo Y, He W, Mou H, Zhang L, Chang J, Peng S, Ojha A, Tavora R, Parcells MS, Luo G, Li W, Zhong G, Choe H, Farzan M, Quinlan BD. Guo Y, et al. Among authors: parcells ms. mBio. 2021 May 11;12(3):e00930-21. doi: 10.1128/mBio.00930-21. mBio. 2021. PMID: 33975938 Free PMC article.

6

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication.

Garcia G Jr, Sharma A, Ramaiah A, Sen C, Purkayastha A, Kohn DB, Parcells MS, Beck S, Kim H, Bakowski MA, Kirkpatrick MG, Riva L, Wolff KC, Han B, Yuen C, Ulmert D, Purbey PK, Scumpia P, Beutler N, Rogers TF, Chatterjee AK, Gabriel G, Bartenschlager R, Gomperts B, Svendsen CN, Betz UAK, Damoiseaux RD, Arumugaswami V. Garcia G Jr, et al. Among authors: parcells ms. Cell Rep. 2021 Apr 6;35(1):108940. doi: 10.1016/j.celrep.2021.108940. Epub 2021 Mar 18. Cell Rep. 2021. PMID: 33784499 Free PMC article.

7

Effect of Insertion and Deletion in the Meq Protein Encoded by Highly Oncogenic Marek's Disease Virus on Transactivation Activity and Virulence.

Sato J, Murata S, Yang Z, Kaufer BB, Fujisawa S, Seo H, Maekawa N, Okagawa T, Konnai S, Osterrieder N, Parcells MS, Ohashi K. Sato J, et al. Among authors: parcells ms. Viruses. 2022 Feb 14;14(2):382. doi: 10.3390/v14020382. Viruses. 2022. PMID: 35215975 Free PMC article.

8

A Rat Model of Prenatal Zika Virus Infection and Associated Long-Term Outcomes.

Sherer ML, Lemanski EA, Patel RT, Wheeler SR, Parcells MS, Schwarz JM. Sherer ML, et al. Among authors: parcells ms. Viruses. 2021 Nov 18;13(11):2298. doi: 10.3390/v13112298. Viruses. 2021. PMID: 34835104 Free PMC article.

9

Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication.

Parcells MS, Arumugaswami V, Prigge JT, Pandya K, Dienglewicz RL. Parcells MS, et al. Poult Sci. 2003 Jun;82(6):893-8. doi: 10.1093/ps/82.6.893. Poult Sci. 2003. PMID: 12817443 Free article. Review.

10

An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines.

Quinlan BD, He W, Mou H, Zhang L, Guo Y, Chang J, Peng S, Ojha A, Tavora R, Parcells MS, Luo G, Li W, Zhong G, Choe H, Farzan M. Quinlan BD, et al. Among authors: parcells ms. bioRxiv. 2020 Nov 18:2020.11.18.388934. doi: 10.1101/2020.11.18.388934. Preprint. bioRxiv. 2020. PMID: 33236008 Free PMC article. Updated.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results